BIOHELIX CORPORATION
- Sector
- Biotech
- Total capital
- $68K
- Federal grants
- $68K
- 2 awards · 2008
- Rank in peer group#2 of 31
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 6 pending · first 2016
- Rank in peer group#11 of 31
Capital timeline
Latest events
- Federal grantAgriculture · Lateral Flow Molecular Assay For Horse Strangles$80K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
1 record has no date or no amount, so it isn’t placed on the timeline.
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1080 | EVOQUANT LLC | — | — |
| 1081 | Zivo Bioscience, Inc. | — | $9.1M |
| 1082 | Forward Therapeutics | — | — |
| 1083 | BIOHELIX CORPORATION | — | — |
| 1084 | LAMASSU BIO INC | — | — |
| 1085 | RERX THERAPEUTICS, INC | — | — |
| 1086 | MOLECULAR INTELLIGENCE LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
No people are linked to this company yet.
People appear here when they are named as related persons in the company's own Form D filings. We don't infer people from social profiles.
Checked: SEC EDGAR Form D related persons through
Patents
- Endonuclease-enhanced Helicase-dependent Amplificationapplication
- Endonuclease-enhanced Helicase-dependent Amplificationgranted
- Step-wise Detection Of Multiple Target Sequences In Isothermal Nucleic Acid Amplification Reactionsapplication
- Endonuclease-enhanced Helicase-dependent Amplificationapplication
- A Method Of Asymmetric Helicase-dependent Amplification For Probe-based Detection Of Targetsapplication
- Identification Of Rna Targets Using Helicasesapplication
- Helicase-dependent Amplification Of Circular Nucleic Acidsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.